Raffaella Butera
Biographic Data
| ID | 7867413 |
|---|---|
| NAME | Raffaella Butera |
| GIVEN NAMES | Raffaella |
| FAMILY NAME | Butera |
| SIGNATURE | BUTERA R |
| AFFILIATIONS | Ospedale Papa Giovanni XXIII |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Consensus Panel Recommendations for the Pharmacological Management of Breastfeeding Women with Postpartum Depression
The ensuing recommendations were as follows: Recommendation 1: Depressive and anxiety disorders, as well as their pharmacological treatment, are not contraindications for breastfeeding. Recommendation 2: The Panel advocates for the continuation of medication that has demonstrated efficacy during pregnancy. If initiating an antidepressant during breastfeeding is necessary, drugs with a superior safety profile and substantial epidemiological data, …
Long-Acting Injectable Antipsychotic Treatment during Pregnancy
This study showed that, despite the small size of the sample under examination, the administration of LAIs do not compromise the normal intrauterine development of the unborn child and there were no evident major malformations
Consensus Panel Recommendations for the Pharmacological Management of Pregnant Women with Depressive Disorders
Considering the state of the art, it is therefore necessary in the first instance to frame the issue of pharmacological choices in pregnant women who need treatment with antidepressant and anxiolytic drugs on the basis of data currently available in the literature. Particular attention must be paid to the evaluation of the risk/benefit ratio, understood both in terms of therapeutic benefit with respect to the potential risks of the treatment on t…
No prominent works on this page.
Long-Acting Injectable Antipsychotic Treatment during Pregnancy
This study showed that, despite the small size of the sample under examination, the administration of LAIs do not compromise the normal intrauterine development of the unborn child and there were no evident major malformations
Consensus Panel Recommendations for the Pharmacological Management of Pregnant Women with Depressive Disorders
Considering the state of the art, it is therefore necessary in the first instance to frame the issue of pharmacological choices in pregnant women who need treatment with antidepressant and anxiolytic drugs on the basis of data currently available in the literature. Particular attention must be paid to the evaluation of the risk/benefit ratio, understood both in terms of therapeutic benefit with respect to the potential risks of the treatment on t…
Consensus Panel Recommendations for the Pharmacological Management of Breastfeeding Women with Postpartum Depression
The ensuing recommendations were as follows: Recommendation 1: Depressive and anxiety disorders, as well as their pharmacological treatment, are not contraindications for breastfeeding. Recommendation 2: The Panel advocates for the continuation of medication that has demonstrated efficacy during pregnancy. If initiating an antidepressant during breastfeeding is necessary, drugs with a superior safety profile and substantial epidemiological data, …
Maternal Mental Health During Pregnancy and Postpartum (3 works) · Medicine (3 works) · Psychiatry (3 works) · Pediatrics (2 works) · Pregnancy (2 works) · Pregnancy and Medication Impact (2 works) · Alternative medicine (1 work) · Antipsychotic (1 work) · Anxiety (1 work) · Bipolar Disorder and Treatment (1 work)